L. Petrucelli

Antiemetic efficacy of single-dose palonosetron and dexamethasone in patients receiving multiple cycles of multiple day-based chemotherapy

V. Lorusso, A. Gnoni, T. Perrone, 2012, Supportive Care in Cancer.

Single dose of palonosetron plus dexamethasone to control nausea, vomiting and to warrant an adequate food intake in patients treated with highly emetogenic chemotherapy (HEC). Preliminary results

V. Lorusso, T. Perrone, M. Giampaglia, 2009, Supportive Care in Cancer.

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III study.

G. Colucci, E. Maiello, V. Lorusso, 2014, International journal of oncology.

Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience

E. Maiello, A. Fabi, V. Lorusso, 2017, Breast Cancer Research and Treatment.

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.

V. Lorusso, A. Rinaldi, L. Biganzoli, 2019, The oncologist.

Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival.

G. Tortora, M. Brunelli, A. Fabi, 2016, Breast.

ADJUVANT CHEMOTHERAPY AFTER NEOADJUVANT CHEMO-RADIOTHERAPY AND SURGERY IN LOCALLY ADVANCED RECTAL CANCER. A SYSTEMATIC REVIEW OF LITERATURE WITH A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS.

P. Delrio, A. Avallone, V. Granata, 2022, Critical reviews in oncology/hematology.